NCT05408481

Brief Summary

Hyponatremia in COVID-19 patients with adrenal insufficiency

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 7, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

June 7, 2022

Status Verified

June 1, 2022

Enrollment Period

6 months

First QC Date

June 4, 2022

Last Update Submit

June 4, 2022

Conditions

COVID-19

Keywords

Hyponatremia

Outcome Measures

Primary Outcomes (1)

  • The effect of hyponatremia on mortality of COVID-19 patient with adrenal insufficiency

    Na level will be measured in COVID-19 patients with adrenal insufficiency

    Baseline

Interventions

Serum cortisol levelDIAGNOSTIC_TEST

Biochemical test

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

COVID-19 patients

You may qualify if:

  • Suspected COVID-19 patients come to isolation hospital in Assuit. 2-Hyponatremia. 3- Adrenal insufficiency

You may not qualify if:

  • Non-cooperative patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19Hyponatremia

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

June 4, 2022

First Posted

June 7, 2022

Study Start

June 1, 2022

Primary Completion

December 1, 2022

Study Completion

March 1, 2023

Last Updated

June 7, 2022

Record last verified: 2022-06